DT-678 / Diapin Therapeutics, Beijing SL Pharma - LARVOL DELTA

Promising clopidogrel analogs may overcome clopidogrel resistance: 2025 update. (PubMed, Biochem Pharmacol) - "The same strategies as those for prasugrel and vicagrel were used to design new compounds, such as tipidogrel, compound 6b, PLD-301, and W-1. All these new compounds in the pipeline are promising antiplatelet drugs, and superior to clopidogrel. DT-678 and evategrel are considered the best clopidogrel analogs that may overcome clopidogrel resistance due to their superior efficacy and safety profiles over clopidogrel."

Journal • Review